Literature DB >> 17510789

Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies.

Maria Cristina Bianchi1, Giuseppina Sgandurra, Michela Tosetti, Roberta Battini, Giovanni Cioni.   

Abstract

Brain MR imaging techniques are important ancillary tests in the diagnosis of a suspected mitochondrial encephalopathy since they provide details on brain structural and metabolic abnormalities. This is particularly true in children where non-specific neurologic symptoms are common, biochemical findings can be marginal and genetic defects may be not discovered. MR imaging modalities include conventional, or structural, imaging (MRI) and functional, or ultrastructural, imaging (spectroscopy, MRS; diffusion, DWI-ADC; perfusion, DSCI--ASL). Among them MRI and MRS are the main tools for diagnosis and work up of MD, and this review will focus mainly on them. The MRI findings of MD are very heterogeneous, as they depend on the metabolic brain defects, age of the patient, stage and severity of the disease. No correlation has been found between genetic defects and neuroimaging picture; however, some relationships between MR findings and clinical phenotypes may be identified. Different combinations of MRI signal abnormalities are often encountered but the most common findings may be summarized into three main MR patterns: (i) non-specific; (ii) specific; (iii) leukodystrophic-like. Regarding the functional MR techniques, only proton MRS plays an important role in demonstrating an oxidative metabolism impairment in the brain since it can show the accumulation of lactate, present as a doublet peak at 1.33 ppm. Assessment of lactate should be always performed on brain tissue and on the ventricular cerebral spinal fluid. As for MRI, metabolic MRS abnormalities can be of different types, and two distinct patterns can be recognized: non-specific and specific. The specific metabolic profiles, although not frequent to find, are highly pathognomonic of MD. The un-specific metabolic profiles add value to structural images in allowing to define the lesion load and to monitor the response to therapy trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510789     DOI: 10.1007/s10540-007-9046-z

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  15 in total

Review 1.  [Cerebral CT and MRI in mitchondrial disorders].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

2.  Metabolic changes in patients with aneurysmal subarachnoid hemorrhage apart from perfusion deficits: neuronal mitochondrial injury?

Authors:  M Wagner; A Jurcoane; C Hildebrand; E Güresir; H Vatter; F E Zanella; J Berkefeld; U Pilatus; E Hattingen
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-22       Impact factor: 3.825

3.  Consensus paper: radiological biomarkers of cerebellar diseases.

Authors:  Leonardo Baldarçara; Stuart Currie; M Hadjivassiliou; Nigel Hoggard; Allison Jack; Andrea P Jackowski; Mario Mascalchi; Cecilia Parazzini; Kathrin Reetz; Andrea Righini; Jörg B Schulz; Alessandra Vella; Sara Jane Webb; Christophe Habas
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

Review 4.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

5.  Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder.

Authors:  Neva M Corrigan; Dennis W W Shaw; Todd L Richards; Annette M Estes; Seth D Friedman; Helen Petropoulos; Alan A Artru; Stephen R Dager
Journal:  J Autism Dev Disord       Date:  2012-01

6.  Aberrant synthesis of ATP synthase resulting from a novel deletion in mitochondrial DNA in an African patient with progressive external ophthalmoplegia.

Authors:  Francois H van der Westhuizen; Joél Smet; Oksana Levanets; Madelein Meissner-Roloff; Roan Louw; Rudy Van Coster; Izelle Smuts
Journal:  J Inherit Metab Dis       Date:  2010-01-16       Impact factor: 4.982

Review 7.  Neuroimaging in mitochondrial disorders.

Authors:  Andrea L Gropman
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

8.  Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder.

Authors:  J Ernst; A Hock; A Henning; E Seifritz; H Boeker; S Grimm
Journal:  Mol Psychiatry       Date:  2016-05-17       Impact factor: 15.992

Review 9.  Pediatric neurodegenerative white matter processes: leukodystrophies and beyond.

Authors:  Jonathan A Phelan; Lisa H Lowe; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2008-04-30

10.  Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis.

Authors:  William T Regenold; Pornima Phatak; Christopher M Marano; Amritpal Sassan; Robert R Conley; Mitchel A Kling
Journal:  Biol Psychiatry       Date:  2008-12-21       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.